These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 20621458)
1. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458 [TBL] [Abstract][Full Text] [Related]
2. In vivo studies on the oridonin-loaded nanostructured lipid carriers. Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of silybin-loaded nanostructured lipid carriers. Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers as a delivery system of biochanin A. Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887 [TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate. Feng F; Zheng D; Zhang D; Duan C; Wang Y; Jia L; Wang F; Liu Y; Gao Q; Zhang Q J Microencapsul; 2011; 28(4):280-5. PubMed ID: 21545318 [TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Tiwari R; Pathak K Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil. Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464 [TBL] [Abstract][Full Text] [Related]
12. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
13. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929 [TBL] [Abstract][Full Text] [Related]
15. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug. Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498 [TBL] [Abstract][Full Text] [Related]
17. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Liu D; Liu Z; Wang L; Zhang C; Zhang N Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845 [TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]